UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

Clinical cancer research, 2018-07, Vol.24 (13), p.3059-3068

2018

Volltextzugriff (PDF)

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies

Clinical cancer research, 2019-05, Vol.25 (10), p.3141-3151

2019

Volltextzugriff (PDF)

Molecular therapeutics for anaplastic thyroid cancer

Seminars in cancer biology, 2020-04, Vol.61, p.23-29

2020

Volltextzugriff (PDF)

The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies

Cancer biology & therapy, 2024-12, Vol.25 (1), p.2332000-2332000

2024

Volltextzugriff (PDF)

Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

The journal of clinical endocrinology and metabolism, 2008-11, Vol.93 (11), p.4331-4341

2008

Volltextzugriff (PDF)

Inhibition of BRAF and ERK1/2 has synergistic effects on thyroid cancer growth in vitro and in vivo

Molecular carcinogenesis, 2021-03, Vol.60 (3), p.201-212

2021

Volltextzugriff (PDF)

Development of new preclinical models to advance adrenocortical carcinoma research

Endocrine-related cancer, 2018-04, Vol.25 (4), p.437-451

2018

Volltextzugriff (PDF)

Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity

Cells (Basel, Switzerland), 2023-05, Vol.12 (10), p.1374

2023

Volltextzugriff (PDF)

Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion

Molecular cancer, 2010-05, Vol.9 (1), p.117-117, Article 117

2010

Volltextzugriff (PDF)

Thyroid cancer cell lines: Critical models to study thyroid cancer biology and new therapeutic targets

Frontiers in endocrinology (Lausanne), 2012, Vol.3, p.81-81

Schweppe, Rebecca E

2012

Volltextzugriff (PDF)

Global Gene Expression Analysis of ERK5 and ERK1/2 Signaling Reveals a Role for HIF-1 in ERK5-mediated Responses

The Journal of biological chemistry, 2006-07, Vol.281 (30), p.20993-21003

2006

Volltextzugriff (PDF)

AKT-independent signaling in PIK3CA-mutant thyroid cancer mediates resistance to dual SRC and MEK1/2 inhibition

Medical oncology (Northwood, London, England), 2023-09, Vol.40 (10), p.299, Article 299

2023

Volltextzugriff (PDF)

Thyroid Cancer Cell Line Misidentification: An Update

The journal of clinical endocrinology and metabolism, 2013-03, Vol.98 (3), p.956-957

Schweppe, Rebecca E

2013

Volltextzugriff (PDF)

Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor-Resistant Melanoma

Molecular cancer therapeutics, 2021-10, Vol.20 (10), p.2049-2060

2021

Volltextzugriff (PDF)

Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2

Molecular cancer research, 2023-09, Vol.21 (9), p.867-880

2023

Volltextzugriff (PDF)

The Characterization of Protein Post-Translational Modifications by Mass Spectrometry

Accounts of chemical research, 2003-06, Vol.36 (6), p.453-461

2003

Volltextzugriff (PDF)

Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells

The journal of clinical endocrinology and metabolism, 2010-01, Vol.95 (1), p.450-455

2010

Volltextzugriff (PDF)

Nuclear Factor κB–Dependent Regulation of Angiogenesis, and Metastasis in an In Vivo Model of Thyroid Cancer Is Associated With Secreted Interleukin-8

The journal of clinical endocrinology and metabolism, 2014-08, Vol.99 (8), p.E1436-E1444

2014

Volltextzugriff (PDF)

Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies

Oncotarget, 2016-08, Vol.7 (32), p.51619-51625

2016

Volltextzugriff (PDF)

Targeted Inhibition of Src Kinase with Dasatinib Blocks Thyroid Cancer Growth and Metastasis

Clinical cancer research, 2012-07, Vol.18 (13), p.3580-3591

2012

Volltextzugriff (PDF)

FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes

Molecular cancer research, 2016-09, Vol.14 (9), p.869-882

2016

Volltextzugriff (PDF)

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis

Oncogene, 2019-04, Vol.38 (14), p.2565-2579

2019

Volltextzugriff (PDF)

Cell Lines as Biological Models: Practical Steps for More Reliable Research

Chemical research in toxicology, 2019-09, Vol.32 (9), p.1733-1736

2019

Volltextzugriff (PDF)

Genetics of Human Thyroid Cancer Cell Lines-Response

Clinical cancer research, 2019-11, Vol.25 (22), p.6883-6884

2019

Volltextzugriff (PDF)

Research ethics dilemmas in thyroid disease

Current opinion in endocrinology, diabetes, and obesity, 2018-10, Vol.25 (5), p.335-340

2018

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(58)
Buchkapitel
(1)

Sprache

Englisch
(59)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(43)
Humans
(30)
Oncology
(23)
Animals
(17)
Cell Line, Tumor
(17)
Thyroid Neoplasms - Pathology
(15)
Mutation
(14)
Cell Biology
(13)
Endocrinology & Metabolism
(13)
Thyroid Neoplasms - Genetics
(13)
Thyroid Cancer
(11)
Mice
(10)
Biochemistry & Molecular Biology
(9)
Protein Kinase Inhibitors - Pharmacology
(8)
Thyroid Neoplasms - Drug Therapy
(8)
Female
(7)
Kinases
(7)
Mice, Nude
(7)
Apoptosis
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies

Molecular therapeutics for anaplastic thyroid cancer

The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies

Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

Inhibition of BRAF and ERK1/2 has synergistic effects on thyroid cancer growth in vitro and in vivo

Development of new preclinical models to advance adrenocortical carcinoma research

Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity

Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion

Thyroid cancer cell lines: Critical models to study thyroid cancer biology and new therapeutic targets

Global Gene Expression Analysis of ERK5 and ERK1/2 Signaling Reveals a Role for HIF-1 in ERK5-mediated Responses

AKT-independent signaling in PIK3CA-mutant thyroid cancer mediates resistance to dual SRC and MEK1/2 inhibition

Thyroid Cancer Cell Line Misidentification: An Update

Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor-Resistant Melanoma

Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2

The Characterization of Protein Post-Translational Modifications by Mass Spectrometry

Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells

Nuclear Factor κB–Dependent Regulation of Angiogenesis, and Metastasis in an In Vivo Model of Thyroid Cancer Is Associated With Secreted Interleukin-8

Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies

Targeted Inhibition of Src Kinase with Dasatinib Blocks Thyroid Cancer Growth and Metastasis

FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis

Cell Lines as Biological Models: Practical Steps for More Reliable Research

Genetics of Human Thyroid Cancer Cell Lines-Response

Research ethics dilemmas in thyroid disease

Suchergebnisse filtern